Equities

Venus Concept Inc

Venus Concept Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.8268
  • Today's Change-0.033 / -3.86%
  • Shares traded2.19m
  • 1 Year change-62.61%
  • Beta0.5040
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.401231
Total Receivables, Net313950
Total Inventory232421
Prepaid expenses6.907.578.40
Other current assets, total0.501.471.03
Total current assets6684110
Property, plant & equipment, net5.847.722.67
Goodwill, net------
Intangibles, net8.451215
Long term investments------
Note receivable - long term112028
Other long term assets0.570.740.82
Total assets94125157
LIABILITIES
Accounts payable9.048.038.42
Accrued expenses152021
Notes payable/short-term debt000
Current portion long-term debt/capital leases4.167.740.54
Other current liabilities, total2.914.285.00
Total current liabilities314035
Total long term debt717077
Total debt757878
Deferred income tax0.0200.05
Minority interest0.570.650.65
Other liabilities, total5.147.043.69
Total liabilities108117116
SHAREHOLDERS EQUITY
Common stock0.030.030.03
Additional paid-in capital248232221
Retained earnings (accumulated deficit)(262)(224)(180)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(14)8.0941
Total liabilities & shareholders' equity94125157
Total common shares outstanding5.535.144.27
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.